Back

Oral anticoagulant use after catheter ablation for atrial fibrillation based on thrombo-embolic risk: future studies will be needed for bleeding high-risk group

European Heart Journal

2 July 2024
Organised by: Logo
Read full article
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY CARDIOVASCULAR PHARMACOLOGY Atrial Fibrillation (AF)

Contributors

Koshiro Kanaoka
Koshiro Kanaoka

Author

Yoshitaka Iwanaga
Yoshitaka Iwanaga

Author

National Cerebral & Cardiovascular Center Suita , Japan

You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources